Insider Transactions Reported by 14 Insiders of NexImmune, Inc.

Industry
Pharmaceutical Preparations
Location
Gaithersburg, MD

There are no Buy or Sell transactions made by insiders since 12/16/2024

NexImmune, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sol J. Barer Director $1.68M Jul 5, 2023
John Trainer Chief Financial Officer $76.7K Apr 4, 2023
Mathias Oelke Chief Science Officer $55K Apr 4, 2023
Timothy Stover VP, Corporate Controller $29.1K Aug 30, 2023
Kristi Jones President and CEO, Director Jun 11, 2024
Albert N. Marchio II Interim Chief Financial Officer Exhibit 24.1 - Power of Attorney Apr 5, 2024
Grant Verstandig Director Jul 5, 2023
Robert Douglas Knight Chief Medical Officer Apr 5, 2022
Leena Gandhi Director Jul 5, 2023
Paul D'Angio Director Jul 5, 2023
Alan S. Roemer Director Nov 21, 2023
Jerome B. Zeldis Executive VP of Research & Dev Apr 5, 2022
Zhengbin Yao Director Jul 5, 2023
Timothy Bertram Director Jul 5, 2023

Recent Insider Transactions by Companies or Individuals for NexImmune, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.